Form 8-K - Current report:
SEC Accession No. 0001193125-20-105931
Filing Date
2020-04-14
Accepted
2020-04-14 09:02:36
Documents
5
Period of Report
2020-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d903904d8k.htm 8-K 32430
2 EX-10.1 d903904dex101.htm EX-10.1 108842
3 EX-99.1 d903904dex991.htm EX-99.1 23626
4 GRAPHIC g903904d903904dex991001.jpg GRAPHIC 3570
5 GRAPHIC g903904d903904dex991002.jpg GRAPHIC 3110
  Complete submission text file 0001193125-20-105931.txt   175684
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 20790163
SIC: 2835 In Vitro & In Vivo Diagnostic Substances